The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis

Current Pharmaceutical Design

Volumn 20, Issue 7, 2014, Pages 1051-1062

  Guo, Zhen Zhen ^a   Wang, Pu ^a   Yi, Zhi Hui ^a   Huang, Zhi Yin ^a   Tang, Cheng Wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Cytokines; Enteral nutrition; Intestinal bacteria; Intestinal barrier; Intestinal inflammation; Intestinal ischemia reperfusion; Intestinal restitution; Melatonin; Somatostatin; Tumor necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; PROBIOTIC AGENT;

COMPLICATION; DRUG EFFECTS; ENTERIC FEEDING; GASTROENTERITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; MICROBIOLOGY; PANCREATITIS; PATHOPHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; CYTOKINES; ENTERAL NUTRITION; GASTROENTERITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; PANCREATITIS; PROBIOTICS;

EID: 84895111308     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990414     Document Type: Review

References (173)

1. Nakajima T, Ueda T, Takeyama Y, et al. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis. Pancreas 2007; 34: 410-6.
2. Flint R, Windsor J. The role of the intestine in the pathophysiology and management of severe acute pancreatitis. HPB 2003; 5: 69-85.
3. Capurso G, Zerboni G, Signoretti M, et al. Role of the Gut Barrier in Acute Pancreatitis. J Clin Gastroenterol 2012; 46: S46-51.
4. Gloor B, Müller C, Worni M, et al. Late mortality in patients with severe acute pancreatitis. Br J Surg 2002; 88: 975-9.
5. Ammori B, Fitzgerald P, Hawkey P, McMahon M. The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 2003; 26: 18-22.
6. Zou XP, Chen M, Wei W, Cao J, Chen L, Tian M. Effects of enteral immunonutrition on the maintenance of gut barrier function and immune function in pigs with severe acute pancreatitis. J Parenter Enteral Nutr 2010; 34: 554-66.
7. Söderholm J. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 2010; 22: 718-33.
8. Natividad JM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications. Pharmacol Res 2013; 69: 42-51.
9. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
10. Biffl W, Moore E. Splanchnic ischaemia/reperfusion and multiple organ failure. Br J Anaesth 1996; 77: 59-70.
11. Mallick IH, Yang W, Winslet MC, Seifalian AM. REVIEW: Ischemia-Reperfusion Injury of the Intestine and Protective Strategies Against Injury. Dig Dis Sci 2004; 49: 1359-77.
12. Stallion A, Kou TD, Miller KA, Dahms BB, Dudgeon DL, Levine AD. IL-10 is not protective in intestinal ischemia reperfusion injury. J Surg Res 2002; 105: 145-52.
13. Wu H, Liu L, Tan Q, et al. Somatostatin limits intestinal ischemia reperfusion injury in macaques via suppression of TLR4-NF-B cytokine pathway. J Gastrointest Surg 2009; 13: 983-93.
14. Zhang X, Zhang J, Song Q, Chen H. Mechanism of acute pancreatitis complicated with injury of intestinal mucosa barrier. J Zhejiang Univ Sci B 2007; 8: 888-95.
15. Choi A, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 9-19.
16. Epstein FH, McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
17. Feng CG, Scanga CA, Collazo-Custodio CM, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)-and TLR4-deficient animals. J Immunol 2003; 171: 4758-64.
18. Hoebe K, Du X, Georgel P, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743-8.
19. Woolhiser MR, Okayama Y, Gilfillan AM, Metcalfe DD. IgG-dependent activation of human mast cells following up-regulation of Fc RI by IFN. Eur J Immunol 2001; 31: 3298-307.
20. Ling L, Qinghua T, Bing H, et al. Modulation of somatostatin on the intestinal mucosal IFN-production in macaque with intestinal ischemia reperfusion. Curr Immunol 2007; 27: 120-4.
21. Andoh A, Fujiyama Y, Araki Y, Kimura T, Tsujikawa T, Bamba T. Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats. Digestion 2001; 63: 103-7.
22. Kanwar S, Hickey MJ, Kubes P. Postischemic inflammation: a role for mast cells in intestine but not in skeletal muscle. Am J Physiol 1998; 275: G212-8.
23. Dib M, Zhao X, Wang X, Andersson R. Role of mast cells in the development of pancreatitis induced multiple organ dysfunction. Br J Surg 2002; 89: 172-8.
24. Tang CW, Lan C, Wang CH, Liu R. Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 2005; 23: 470-5.
25. Yang H, Jin Y, Li M, Wang CH, Tang CW. Disturbances of mesenteric lymph flow and in vivo intestinal lymphocyte trafficking during early gut injury induced by ischemia-reperfusion in rats. Lymphology 2012; 45: 130-9.
26. Shibahara T, Miyazaki K, Sato D, et al. Alteration of intestinal epithelial function by intraepithelial lymphocyte homing. J Gastroenterol 2005; 40: 878-86.
27. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-9.
28. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005; 115: 1-20.
29. Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990; 265: 1531-6.
30. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9:401-10.
31. Yang F, Wu H, Li Y, et al. Prevention of Severe Acute Pancreatitis With Octreotide in Obese Patients: A Prospective Multi-Center Randomized Controlled Trial. Pancreas 2012; 41: 1206-12.
32. Granell S, Pereda J, Gómez-Cambronero L, et al. Circulating TNF-and its soluble receptors during experimental acute pancreatitis. Cytokine 2004; 25: 187-91.
33. Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock 2007; 28: 130-40.
34. Sendler M, Dummer A, Weiss FU, et al. Tumour necrosis factor secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut 2013; 62: 430-9.
35. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-induced single-cell apoptosis. FASEB J 2000; 14: 1749-53.
36. van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995; 3: 1-12.
37. Montero-Julian FA, Klein B, Gautherot E, Brailly H. Pharmacokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies. Blood 1995; 85: 917-24.
38. Matull WR, Pereira SP, O'Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol 2006; 59: 340-4.
39. Pini M, Rhodes DH, Castellanos KJ, et al. Role of IL-6 in the resolution of pancreatitis in obese mice. J Leukoc Biol 2012; 91: 957-66.
40. Thornberry NA, Bull HG. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-74.
41. Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-44.
42. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993; 292: 617-27.
43. Bussolino F, Camussi G, Tetta C, Garbarino G, Bosia A, Baglioni C. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1. J Lipid Mediat 1990; 2: S15-22.
44. Wang R, Yang F, Wu H, et al. Randomized clinical trial: high-dose vs low-dose octreotide in the treatment of acute pancreatitis. Peptides 2013; 40: 57-64.
45. Bubenik GA. Review: gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-48.
46. Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 2011; 17: 3888-98.
47. Bubenik G, Pang S, Hacker R, Smith P. Melatonin concentrations in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 21: 251-6.
48. Huether G, Poeggeler B, Reimer A, George A. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992; 51: 945-53.
49. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58: 65-80.
50. Jaworek J, Brzozowski T, Konturek SJ. Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res 2005; 38: 73-83.
51. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, et al. Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats. J Physiol Pharmacol 2007; 58: 81-95.
52. Reiter RJ, Tan D, Kim SJ, et al. Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Ageing Dev 1999; 110: 157-73.
53. Jaworek J, Zwirska-Korczala K, Szklarczyk J, et al. Pinealectomy aggravates acute pancreatitis in the rat. Pharmacol Rep 2010; 62: 864-73.
54. Ustundag B, Kazez A, Demirbag M, Canatan H, Halifeoglu I, Ozercan IH. Protective effect of melatonin on antioxidative system in experimental ischemia-reperfusion of rat small intestine. Cell Physiol Biochem 2000; 10: 229-36.
55. Ochoa JJ, Díaz Castro J, Kajarabille N, et al. Melatonin supplementation ameliorates oxidative stress and inflammatory signaling induced by strenuous exercise in adult human males. J Pineal Res 2011; 51: 373-80.
56. Shagirtha K, Muthumani M, Prabu SM. Melatonin abrogates cadmium induced oxidative stress related neurotoxicity in rats. Eur Rev Med Pharmacol Sci 2011; 15: 1039-50.
57. Reiter RJ, Paredes SD, Korkmaz A, Jou MJ, Tan DX. Melatonin combats molecular terrorism at the mitochondrial level. Interdiscip Toxicol 2008; 1: 137-49.
58. Jung KH, Hong SW, Zheng HM, et al. Melatonin ameliorates cerulein induced pancreatitis by the modulation of nuclear erythroid 2 related factor 2 and nuclear factor kappaB in rats. J Pineal Res 2010; 48: 239-50.
59. Jaworek J, Leja Szpak A, Bonior J, et al. Protective effect of melatonin and its precursor L tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2002; 34: 40-52.
60. Jaworek J, Szklarczyk J, Jaworek AK, et al. Protective Effect of Melatonin on Acute Pancreatitis. Int J Inflam 2012; 2012: 173675.
61. Szabolcs A, Reiter RJ, Letoha T, et al. Effect of melatonin on the severity of L-arginine-induced experimental acute pancreatitis in rats. World J Gastroenterol 2006; 12: 251-8.
62. Ganguly K, Sharma AV, Reiter RJ, Swarnakar S. Melatonin promotes angiogenesis during protection and healing of indomethacin induced gastric ulcer: role of matrix metaloproteinase 2. J Pineal Res 2010; 49: 130-40.
63. Muñoz-Casares FC, Padillo FJ, Briceño J, et al. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J Pineal Res 2006; 40: 195-203.
64. Soyb r G, Topuzlu C, Odaba O, Dolay K, Bilir A, KÖksoy F. The effects of melatonin on angiogenesis and wound healing. Surg Today 2003; 33: 896-901.
65. Thadepalli H, Lou MA, Bach VT, Matsui TK, Mandal AK. Microflora of the human small intestine. Am J Surg 1979; 138: 845-50.
66. Fan Hua, WU Hao, Tan Qinghua, HU Bing, Chengwei T. Relevance of Intestinal Mucosal Barrier Damage and Alteration of Luminal Microflora after Intestinal Ischemia Reperfusion Injury in Macaque. Chin J Gastroenteral 2006; 11: 268-72.
67. Esper A, Burnham E, Moss M. The effect of alcohol abuse on ARDS and multiple organ dysfunction. Minerva Anestesiol 2006; 72: 375-81.
68. Moss M, Parsons PE, Steinberg KP, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003; 31: 869-77.
69. Nieuwenhuijzen GA, Goris RJ. The gut: the motor of multiple organ dysfunction syndrome? Curr Opin Clin Nutr Metab Care 1999; 2: 399-404.
70. Zhou C, Li J, Wang H, Tang C. Decreased somatostatin is related to the hypersensitivity of intestinal epithelia to LPS via upregulated TLR4-TBK1 pathway in rats chronically exposed to ethanol. Alcohol 2009; 43: 293-303.
71. Zyromski NJ, Mathur A, Pitt HA, et al. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008; 295: G552-8.
72. Muccioli GG, Naslain D, Bäckhed F, et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6:392.
73. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005; 5: 70-5.
74. Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb DC. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology 2006; 6: 279-85.
75. Araki H, Nishihara T, Matsuda M, et al. Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet. Gut 2008; 57: 1431-40.
76. De Waele B, Vanmierlo B, Van Nieuwenhove Y, Delvaux G. Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas 2006; 32: 343-5.
77. Tian XF, Yao JH, Li YH, et al. Protective effect of pyrrolidine dithiocar-bamate on liver injury induced by intestinal ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int 2006; 5: 90-5.
78. Wang J, Qiao L, Li Y, Yang G. Ginsenoside Rb1 attenuates intestinal ischemia-reperfusioninduced liver injury by inhibiting NF-kappaB activation. Exp Mol Med 2008; 40: 686-98.
79. Zhao HD, Zhang F, Shen G, et al. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J Gastroenterol 2010; 16: 3002-10.
80. Ogura J, Terada Y, Tsujimoto T, et al. The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion. J Pharm Pharm Sci 2012; 15: 616-31.
81. Tomita M, Kishimoto H, Takizawa Y, Hayashi M. Effects of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodamine123 in rat. Drug Metab Pharmacokinet 2009; 24: 428-37.
82. Atici AE, Kaya Y, Coskun T, Aral E, Var A. Intestinal ischemia-reperfusion impairs liver regeneration after partial hepatectomy in rats. Hepatogastroenterology 2003; 50: 661-5.
83. Chen P, Hu B, Tan Q, et al. Role of neurocrine somatostatin on sphincter of Oddi contractility and intestinal ischemia reperfusion induced acute pancreatitis in macaques. Neurogastroenterol Motil 2010; 22: 935-42.
84. Ferrer JV, Ariceta J, Guerrero D, Balén E, Herrera J, Lera JM. Prevention by somatostatine and N-acetylcisteine of multiorgan failure mediated by oxidative stress after intestinal ischemia. Transplant Proc 1999; 31: 2570-1.
85. Rau B, Baumgart K, Krüger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med 2003; 29: 622-9.
86. O'Hair DP, Hoffman RG, Schroeder H, Wilson SD. Octreotide in the treatment of acute pancreatitis: a prospective, randomized trial. Gastroenterology 1993; 104: A326.
87. Beechey-Newman N. Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Dig Dis Sci 1993; 38: 644-7.
88. Binder M, Uhl W, Friess H, Malfertheiner P, Büchler MW. Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. Digestion 1994; 55: 20-3.
89. Paran H, Neufeld D, Mayo A, et al. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis. J Am Coll Surg 1995; 181: 121-4.
90. Fiedler F, Jauernig G, Keim V, Richter A, Bender H. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure. Intensive Care Med 1996; 22: 909-15.
91. McKay C, Baxter J, Imrie C. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis. Int J Pancreatol 1997; 21: 13-9.
92. Karakoyunlar Ö, Sivrel E, Tanir N, Denecli AG. High dose octreotide in the management of acute pancreatitis. Hepatogastroenterology 1999; 46: 1968-72.
93. Paran H, Mayo A, Paran D, et al. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 2000; 45: 2247-51.
94. Nikou GC, Arnaoutis TP, Giamarellos-Bourboulis EJ, et al. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity. Hepatogastroenterology 2001; 48: 1754-7.
95. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001; 426: 1-10.
96. Gülben K, Özdemir H, Berbero lu U, et al. Melatonin modulates the severity of taurocholate-induced acute pancreatitis in the rat. Dig Dis Sci 2010; 55: 941-6.
97. Chen HM, Chen JC, Ng CJ, Chiu DF, Chen MF. Melatonin reduces pancreatic prostaglandins production and protects against caerulein induced pancreatitis in rats. J Pineal Res 2006; 40: 34-9.
98. Jaworek J, Konturek S, Leja-Szpak A, et al. Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53: 791-804.
99. Col C, Dinler K, Hasdemir O, Buyukasik O, Bugdayci G. Oxidative stress and lipid peroxidation products: effect of pinealectomy or exogenous melatonin injections on biomarkers of tissue damage during acute pancreatitis. Hepatobiliary Pancreat Dis Int 2010; 9: 78-82.
100. Çöl C, Dinler K, Hasdemir O, Büyükaik O, Firat T, Kükner A. Evaluation of the effects of melatonin administration intraperitoneally on rats with acute pancreatitis induced by ductal ligation. Turk J Gastroenterol 2010; 21: 433-8.
101. Al-Ghoul WM, Abu-Shaqra S, Park BG, Fazal N. Melatonin Plays a Protective Role in Postburn Rodent Gut Pathophysiology. Int J Biol Sci 2010; 6: 282-93.
102. Sözen S, Topuz Ö, Uzun AS, Çetinkünar S, Das K. Prevention of bacterial translocation using Glutamine and Melatonin in small bowel ischemia and reperfusion in rats. Ann Ital Chir 2012; 83: 143-8.
103. Ozacmak VH, Sayan H, Arslan SO, Altaner S, Aktas RG. Protective effect of melatonin on contractile activity and oxidative injury induced by ischemia and reperfusion of rat ileum. Life Sci 2005; 76: 1575-88.
104. Barlas A, Çevik H, Arbak S, et al. Melatonin protects against pancreaticobiliary inflammation and associated remote organ injury in rats: role of neutrophils. J Pineal Res 2004; 37: 267-75.
105. Erefolu M, Gül M, Ates B, Batçiolu K, Selimolu MA. Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol 2006; 12: 259-64.
106. Erefolu M, Gül M, Turan F. Comparative effects of several therapatic agents on hepatic damage induced by acute experimental pancreatitis. Dig Dis Sci 2008; 53: 1303-10.
107. Çöl C, Dinler K, Hasdemir O, Büyükaik O, Budayci G, Terzi H. Exogenous melatonin treatment reduces hepatocyte damage in rats with experimental acute pancreatitis. J Hepatobiliary Pancreat Sci 2010; 17: 682-7.
108. Huai JP, Sun XC, Chen MJ, et al. Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22. World J Gastroenterol 2012; 18: 5122-8.
109. Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997; 6: 40-4.
110. Smolen JS, Emery P. Infliximab: 12 years of experience. Arthritis Res Ther 2011; 13(Suppl 1): S2.
111. Grewal HP, Moheyel Din A, Gaber L, Kotb M, Gaber AO. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994; 167: 214-8.
112. Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNF therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 1996; 171: 274-80.
113. Oruc N, Ozutemiz AO, Yukselen V, et al. Infliximab: A New Therapeutic Agent in Acute Pancreatitis? Pancreas 2004; 28: e1-8.
114. Luo S, Wang R, Jiang W, Lin X, Qiu P, Yan G. A novel recombinant snake venom metalloproteinase from Agkistrodon acutus protects against taurocholate-induced severe acute pancreatitis in rats. Biochimie 2010; 92: 1354-61.
115. Aydin S, Isik AT, Unal B, et al. Effects of infliximab on bacterial translocation in experimental acute necrotizing pancreatitis. Indian J Med Res 2012; 135: 656-61.
116. Yilmaz M, Tekekoglu S, Herek O, Ozmen O, Sahinduran S, Buyukoglu T. Ameliorative effect of adalimumab on experimentally induced acute pancreatitis in rats. Pancreas 2010; 39: 1238-42.
117. Huang YX, Li WD, Jia L, et al. Infliximab Enhances the Therapeutic Effectiveness of Octreotide on Acute Necrotizing Pancreatitis in Rat Model. Pancreas 2012; 41: 849-54.
118. Guice K, Oldham KT, Remick DG, Kunkel SL, Ward PA. Antitumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res 1991; 51: 495-9.
119. Buscaglia JM, Simons BW, Prosser BJ, et al. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines. JOP 2008; 9: 456-67.
120. Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996; 120: 515-21.
121. Triantafillidis JK, Cheracakis P, Hereti IA, Argyros N, Karra E. Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am J Gastroenterol 2000; 95: 3334-6.
122. Fefferman DS, Alsahli M, Lodhavia PJ, Shah SA, Farrell RJ. Re: Triantafillidis et al.Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment. Am J Gastroenterol 2001; 96: 2510-1.
123. Jimenez-Fernandez SG, Tremoulet AH. Infliximab Treatment of Pancreatitis Complicating Acute Kawasaki Disease. Pediatr Infect Dis J 2012; 31: 1087-9.
124. Malleo G, Mazzon E, Genovese T, et al. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 2007; 27: 542-51.
125. Yilmaz M, Topsakal S, Herek O, et al. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res 2009; 154: 241-9.
126. Ikeda T, Hiromatsu K, Hotokezaka M, Chijiiwa K. Up-regulation of intestinal toll-Like receptors and cytokines expressions change after TPN administration and a lack of enteral feeding. J Surg Res 2010; 160: 244-52.
127. Guzy C, Schirbel A, Paclik D, Wiedenmann B, Dignass A, Sturm A. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr 2009; 48: 12-21.
128. Ioannidis O, Lavrentieva A, Botsios D. Nutrition support in acute pancreatitis. JOP 2008; 9: 375-90.
129. Windsor A, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431-5.
130. Dignass AU. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 2001; 7: 68-77.
131. Monk JM, Woodward B. The blood level of transforming growth factor-b rises in the early stages of acute protein and energy deficit in the weanling mouse. Br J Nutr 2010; 103: 886-9.
132. Eatock F, Chong P, Menezes N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005; 100: 432-9.
133. Eckerwall GE, Axelsson JB, Andersson RG. Early nasogastric feeding in predicted severe acute pancreatitis: A clinical, randomized study. Ann Surg 2006; 244: 959-67.
134. Kumar A, Singh N, Prakash S, Saraya A, Joshi YK. Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol 2006; 40: 431-4.
135. Mansfield CS, James FE, Steiner JM, Suchodolski JS, Robertson ID, Hosgood G. A pilot study to assess tolerability of early enteral nutrition via esophagostomy tube feeding in dogs with severe acute pancreatitis. J Vet Intern Med 2011; 25: 419-25.
136. Go JT, Harper RG, Sia CG, Teichberg S, Wapnir RA. Oral rehydration solutions: increased water and sodium absorption by addition of a viscosity-enhancing agent in a rat model of chronic osmotic diarrhea. J Pediatr Gastroenterol Nutr 1994; 19: 410-6.
137. Lin R, Murtazina R, Cha B, et al. D-Glucose Acts via Sodium/Glucose Cotransporter 1 to Increase NHE3 in Mouse Jejunal Brush Border by a Na+/H+ Exchange Regulatory Factor 2-Dependent Process. Gastroenterology 2011; 140: 560-71.
138. Lee SH, Kim T, Park ES, et al. NHE10, an osteoclast-specific member of the Na+/H+ exchanger family, regulates osteoclast differentiation and survival. Biochem Biophys Res Commun 2008; 369: 320-6.
139. De Vito P. The sodium/hydrogen exchanger: a possible mediator of immunity. Cell Immunol 2006; 240: 69-85.
140. Dudeja PK, Rao DD, Syed I, et al. Intestinal distribution of human Na+/H+ exchanger isoforms NHE-1, NHE-2, and NHE-3 mRNA. Am J Physiol 1996; 271: G483-93.
141. Xu H, Chen R, Ghishan FK. Subcloning, localization, and expression of the rat intestinal sodium-hydrogen exchanger isoform 8. Am J Physiol Gastrointest Liver Physiol 2005; 289: G36-41.
142. Moeser AJ, Nighot PK, Ryan KA, Simpson JE, Clarke LL, Blikslager AT. Mice lacking the Na+/H+ exchanger 2 have impaired recovery of intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2008; 295: G791-7.
143. Xue L, Aihara E, Wang TC, Montrose MH. Trefoil factor 2 requires Na/H exchanger 2 activity to enhance mouse gastric epithelial repair. J Biol Chem 2011; 286: 38375-82.
144. Stock C, Schwab A. Role of the Na+/H+ exchanger NHE1 in cell migration. Acta Physiol (Oxf) 2006; 187: 149-57.
145. Czepán M, Rakonczay Z, Varró A, et al. NHE1 activity contributes to migration and is necessary for proliferation of human gastric myofibroblasts. Pflugers Arch 2012; 463: 459-75.
146. Tabor CW, Tabor H. Polyamines. Annu Rev Biochem 1984; 53: 749-90.
147. Rao JN, Rathor N, Zhuang R, et al. Polyamines regulate intestinal epithelial restitution through TRPC1-mediated Ca + signaling by differentially modulating STIM1 and STIM2. Am J Physiol Cell Physiol 2012; 303: C308-17.
148. Guo X, Rao JN, Liu L, Rizvi M, Turner DJ, Wang JY. Polyamines regulate -catenin tyrosine phosphorylation via Ca2+ during intestinal epithelial cell migration. Am J Physiol Cell Physiol 2002; 283: C722-34.
149. Guo X, Rao JN, Liu L, et al. Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am J Physiol Cell Physiol 2003; 285: C1174-87.
150. Rao JN, Liu L, Zou T, et al. Polyamines are required for phospholipase C-1 expression promoting intestinal epithelial restitution after wounding. Am J Physiol Gastrointest Liver Physiol 2007; 292: G335-43.
151. Young VR, Ajami AM. Glutamine: the emperor or his clothes? J Nutr 2001; 131: 2449S-59S.
152. Coeffier M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr 2003; 22: 407-13.
153. Wasa M, Wang H, Shimizu Y, Fukuzawa M. Glutamine stimulates amino acid transport during ischemia-reperfusion in human intestinal epithelial cells. J Surg Res 2005; 123: 75-81.
154. Mondello S, Galuppo M, Mazzon E, et al. Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. Eur J Pharmacol 2010; 643: 304-15.
155. Kessel A, Toubi E, Pavlotzky E, et al. Treatment with glutamine is associated with down regulation of Toll like receptor 4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat. Clin Exp Immunol 2008; 151: 341-7.
156. Sukhotnik I, Khateeb K, Mogilner JG, et al. Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following ischemia-reperfusion injury in the rat. Dig Dis Sci 2007; 52: 1497-504.
157. Ban K, Kozar RA. Enteral glutamine: a novel mediator of PPAR in the postischemic gut. J Leukoc Biol 2008; 84: 595-9.
158. Xu XF, Lou WH, Wang DS, Jin da Y, Ni XL, Wu ZH. Influence of glutamine on pancreatic blood flow and apoptosis of pancreatic acinar in rats with severe acute pancreatitis. Chin J Dig Dis 2006; 7: 121-6.
159. Huang XX, Wang XP, Ma JJ, Jing DD, Wang PW, Wu K. Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial. Zhonghua Yi Xue Za Zhi 2008; 88: 2407-9.
160. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
161. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982; 83: 424-9.
162. Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. The luminal short-chain fatty acid butyrate modulates NF-B activity in a human colonic epithelial cell line. Gastroenterology 2000; 118: 724-34.
163. Hamer HM, Jonkers DM, Bast A, et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2009; 28: 88-93.
164. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17: 1519-28.
165. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription. Dig Dis Sci 2012; 57: 3126-35.
166. Plöger S, Stumpff F, Penner GB, et al. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 2012; 1258: 52-9.
167. Aguilar-Nascimento JE, Salomão AB, Nochi RJ Jr, Nascimento M, Neves Jde S. Intraluminal injection of short chain fatty acids diminishes intestinal mucosa injury in experimental ischemia-reperfusion. Acta Cir Bras 2006; 21: 21-5.
168. Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222: 57-65.
169. Takeda K, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13: 42-7.
170. Working Party of the British Society of Gastroenterology, Association of Surgeons of Great Britain and Ireland, Pancreatic Society of Great Britain and Ireland, Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut 2005; 54: iii1-9.
171. Zareie M, Johnson-Henry K, Jury J, et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55: 1553-60.
172. Mangiante G, Colucci G, Canepari P, et al. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg 2001; 18: 47-50.
173. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-9.